Literature DB >> 11029660

LUCA15, a putative tumour suppressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells.

H Edamatsu1, Y Kaziro, H Itoh.   

Abstract

BACKGROUND: The proliferation of mammalian cells is controlled by various intracellular mitogenic signalling pathways. In the intracellular pathways, Ras is involved in the activation of proto-oncogenes such as an immediate early gene c-fos. The somatic mutations of ras genes that elicit the constitutive activation of Ras have been found in tumours. Although these findings suggest that the constitutive activation of Ras-mediated pathways alters the expression of a set of genes involving tumorigenesis, these genes have not yet fully been studied.
RESULTS: To study the up- or down-regulated genes in ras-transformed cells, we analysed Rat-1 transfectants expressing Ras(G12V) mutant protein in response to isopropyl-1-beta-thio-D-galactoside using a differential display. We found that the mRNA level of rat homologue of LUCA15, which has been cloned initially as a putative tumour suppressor gene mapped on human chromosome 3, was down-regulated by the expression of Ras(G12V). Epitope-tagged LUCA15 protein was localized in nuclei and had the ability to bind poly(G) RNA homopolymers in vitro. Moreover, ectopic expression of LUCA15 in human fibrosarcoma HT1080 cells suppressed the cell growth.
CONCLUSION: These results demonstrate that LUCA15 is one of the down-regulated genes in ras-transformed cells, and suggests that LUCA15 may function as a negative regulator of cell proliferation by the alteration of its mRNA level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029660     DOI: 10.1046/j.1365-2443.2000.00370.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  18 in total

1.  Targeting zinc finger domains with small molecules: solution structure and binding studies of the RanBP2-type zinc finger of RBM5.

Authors:  Biancamaria Farina; Roberto Fattorusso; Maurizio Pellecchia
Journal:  Chembiochem       Date:  2011-12-16       Impact factor: 3.164

Review 2.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

3.  The conserved splicing factor SUA controls alternative splicing of the developmental regulator ABI3 in Arabidopsis.

Authors:  Matteo Sugliani; Vittoria Brambilla; Emile J M Clerkx; Maarten Koornneef; Wim J J Soppe
Journal:  Plant Cell       Date:  2010-06-04       Impact factor: 11.277

Review 4.  KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach.

Authors:  Javier de Castro Carpeño; Cristóbal Belda-Iniesta
Journal:  Transl Lung Cancer Res       Date:  2013-04

5.  Zinc ions negatively regulate proapoptotic signaling in cells expressing oncogenic mutant Ras.

Authors:  Hironori Edamatsu
Journal:  Biometals       Date:  2022-02-25       Impact factor: 2.949

6.  Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.

Authors:  Amer M Mirza; Stephan Gysin; Nisar Malek; Kei-ichi Nakayama; James M Roberts; Martin McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 7.  Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.

Authors:  Mo Chen; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-23       Impact factor: 94.444

8.  Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5.

Authors:  Kazuo Fushimi; Payal Ray; Amar Kar; Lei Wang; Leslie C Sutherland; Jane Y Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-07       Impact factor: 11.205

9.  The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.

Authors:  Juliana J Oh; Ashley K Koegel; Diana T Phan; Ali Razfar; Dennis J Slamon
Journal:  Lung Cancer       Date:  2007-07-02       Impact factor: 5.705

10.  Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues.

Authors:  Hong Liang; Jie Zhang; Chen Shao; Lijing Zhao; Wei Xu; Leslie C Sutherland; Ke Wang
Journal:  J Exp Clin Cancer Res       Date:  2012-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.